Genomic Health Inc. (GHDX) Misses Q1 EPS by 3c
Genomic Health Inc. (NASDAQ: GHDX) reported Q1 EPS of ($0.01), $0.03 worse than the analyst estimate of $0.02. Revenue for the quarter came in at $49.8 million versus the consensus estimate of $48.69 million.